0001567619-21-014218.txt : 20210730
0001567619-21-014218.hdr.sgml : 20210730
20210730162617
ACCESSION NUMBER: 0001567619-21-014218
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210729
FILED AS OF DATE: 20210730
DATE AS OF CHANGE: 20210730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryali Sriram
CENTRAL INDEX KEY: 0001762893
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 211132901
MAIL ADDRESS:
STREET 1: C/O EIGER BIOPHARMACEUTICALS, INC.
STREET 2: 2155 PARK BLVD.
CITY: PALO ALTO
STATE: CA
ZIP: 94306
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
doc1.xml
FORM 4
X0306
4
2021-07-29
0
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001762893
Ryali Sriram
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
8.15
2021-07-29
4
A
0
30000
0.00
A
2031-07-28
Common Stock
30000
30000
D
The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date.
/s/ Sriram Ryali
2021-07-30